Impact of C‐Reactive Protein Kinetics on the Prognosis of the Patient With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin
Kazutaka Saito is an Editorial Board member of the International Journal of Urology and a co-author of this article. To minimize bias, he was excluded from all editorial decision-making related to the acceptance of this article for publication.
Authors
- Kiyoshi Setoguchi (ORCID: https://orcid.org/0000-0003-2298-7478)
- Kazutaka Saito (ORCID: https://orcid.org/0000-0002-7261-0188)
- Akinori Nakayama (ORCID: https://orcid.org/0000-0001-9297-2664)
- Hiroki Tsujioka (ORCID: https://orcid.org/0000-0002-5943-0641)
- Keita Izumi (ORCID: https://orcid.org/0000-0002-9785-6432)
Institutions
- Dokkyo Medical University Saitama Medical Center (JP)
- Social Insurance Saitama Chuo Hospital (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1111/iju.70241
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01